CORCEPT THERAPEUTICS INC Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
CORCEPT THERAPEUTICS INC (CORT) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 300.00 thousand shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2022-05-05
- CORCEPT THERAPEUTICS INC share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2022-03-31 was 300.00K shares, a 62.50% decline year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2021-09-30 was 200.00K shares.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2021-06-30 was 100.00K shares, a 0.00% change year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2021-03-31 was 800.00K shares.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 9 month |
|---|---|---|---|
| 2022-03-31 | 300.00K shares 10-Q · filed 2022-05-05 | ||
| 2021-09-30 | 200.00K shares 10-Q · filed 2021-11-03 | 300.00K shares derived: sum of 2 quarters · filed 2021-11-03 | 1.20M shares 10-Q · filed 2021-11-03 |
| 2021-06-30 | 100.00K shares 10-Q · filed 2021-07-29 | 1.00M shares 10-Q · filed 2021-07-29 | |
| 2021-03-31 | 800.00K shares 10-Q · filed 2022-05-05 | ||
| 2020-06-30 | 100.00K shares 10-Q · filed 2021-07-29 | 100.00K shares 10-Q · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |